Evidence map›Paper›PMID 34767259›Full record

ArticleThe Journal of pathology2022

Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells.

Stephen D Lee, Jungeun Song, Veronique G LeBlanc, Marco A Marra

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Cancers · 2023
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Stephen D LeeCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.ORCID 0000-0002-9402-4331
Jungeun SongCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.
Veronique G LeBlancCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.ORCID 0000-0003-4908-3567
Marco A MarraCanada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, Canada.ORCID 0000-0001-7146-7175
Canada's Michael Smith Genome Sciences Centre · CAUniversity of British Columbia · CA

Funding

CIHR 143288
6 · The paper itself

Abstract

Capicua (CIC)'s transcriptional repressor function is implicated in neurodevelopment and in oligodendroglioma (ODG) aetiology. However, CIC's role in these contexts remains obscure, primarily from our currently limited knowledge regarding its biological functions. Moreover, CIC mutations in ODG invariably co-occur with a neomorphic IDH1/2 mutation, yet the functional relationship between these two genetic events is unknown. Here, we analysed models derived from an E6/E7/hTERT-immortalized (i.e. p53- and RB-deficient) normal human astrocyte cell line. To examine the consequences of CIC loss, we compared transcriptomic and epigenomic profiles between CIC wild-type and knockout cell lines, with and without mutant IDH1 expression. Our analyses revealed dysregulation of neurodevelopmental genes in association with CIC loss. CIC ChIP-seq was also performed to expand upon the currently limited ensemble of known CIC target genes. Among the newly identified direct CIC target genes were EPHA2 and ID1, whose functions are linked to neurodevelopment and the tumourigenicity of in vivo glioma tumour models. NFIA, a known mediator of gliogenesis, was discovered to be uniquely overexpressed in CIC-knockout cells expressing mutant IDH1-R132H protein. These results identify neurodevelopment and specific genes within this context as candidate targets through which CIC alterations may contribute to the progression of IDH-mutant gliomas. © 2021 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Indexed as

EpigenomeEpigenomicsGene Expression ProfilingMutationTranscriptomeAstrocytesBrain NeoplasmsCell Line, TransformedCell Transformation, NeoplasticDNA MethylationEpigenesis, GeneticGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansIsocitrate DehydrogenaseCIC protein, humanEPHA2 protein, humanIDH1 protein, humanIsocitrate DehydrogenaseNFIA protein, humanNFI Transcription FactorsReceptor, EphA2Repressor Proteinscapicua transcriptional repressorepigenomicsneomorphic IDH mutationtranscriptomics

Identifiers

PMID34767259
PMCPMC9305137
OpenAlexW3214288468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.